TITLE

2010 SFO rapport focuses on complex management of uveitis

PUB. DATE
June 2010
SOURCE
Ocular Surgery News;6/25/2010, Vol. 28 Issue 12, p18
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article provides information about the complex management of uveitis, according to Antoine Brézin, coordinator of the 2010 SFO rapport on uveitis.
ACCESSION #
53018384

 

Related Articles

  • Vision system enables easy transition to coaxial MICS. Packer, Mark // Ophthalmology Times;9/1/2008, Vol. 33 Issue 17, p12 

    The article focuses on the study conducted by cataract surgeon Dominique Monnet, which revealed that enhancement systems performing coaxial microincision cataract surgery (C-MICS) enables safe and efficient phacoemulsification. According to Monnet and Antoine Brézin's evaluation on the first...

  • Consider referral for uveitis. Sweeney, Tara // Ophthalmology Times;8/15/96, Vol. 21 Issue 22, p16 

    Reports that delayed referral is one of the factor for the decreased outcome in uveitis treatment, according to Stephen Foster of the Massachusetts Eye & Ear Infirmary (MEEI) in Boston. Responsibility of general ophthalmologist to refer uveitis patients for multiple recurrences, granulomatous...

  • Uveitis and rifabutin therapy.  // American Family Physician;11/1/1994, Vol. 50 Issue 6, p1391 

    Reports that rifabutin (Myscobutin) therapy is associated with the development of uveitis. Recommendation of the U.S. Public Health Service Task Force n 1993 of rifabutin; Possibility of uveitis on administration of higher doses of rifabutin.

  • Metoprolol responding uveitis: reply. Kassif, Y; Rehany, U; Rumelt, S // Eye;Jun2005, Vol. 19 Issue 6, p720 

    Presents a letter to the editor in response to a comment about the use of metoprolol for uveitis.

  • Metoprolol responding uveitis. Masood, I // Eye;Jun2005, Vol. 19 Issue 6, p719 

    Presents a letter to the editor referring to a case of panuveitis responding to oral metoprolol therapy.

  • Management of Immune-Mediated Uveitis. Smith, J.R.; Rosenbaum, J.T. // BioDrugs;2000, Vol. 13 Issue 1, p9 

    Immune-mediated uveitis is a collective term referring to a group of potentially blinding intraocular inflammations which may coexist with systemic inflammatory diseases. T lymphocytes appear to play an important pathogenic role in uveitis, and these cells are therefore the logical target of...

  • Treat early and embrace the evidence in favour of anti-TNF-α therapy for Behçet's uveitis. Lee, Richard W. J.; Dick, Andrew D. // British Journal of Ophthalmology;Mar2010, Vol. 94 Issue 3, p2 

    The author reflects on the need to embrace medical developments in favor of the anti-tumour necrosis factor therapy for the treatment of Behcet's uveitis.

  • Speaker shares experiences managing uveitis.  // Ocular Surgery News;2/25/2014, Vol. 32 Issue 4, p29 

    The article discusses the experience of ophthalmologist Dr. Thomas A. Albini in making a decision to treat tuberculosis when there is high degree of suspicion that a patient has tuberculosis despite obtaining negative sputum test result, using leopard spots detected on ocular imaging as a clue.

  • Cancer-causing Drug Treats Uveitis.  // Review of Ophthalmology;Mar2002, Vol. 9 Issue 3, p11 

    Focuses on the effectiveness of chlorambucil in treating uveitis in the Chicago, Illinois. Percentage rate of treated patients experience on recurrence of uveitis; Number of patients treated with high-dose, short-term chlorambucil; Prohibition of drugs for long-term use.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics